Literature DB >> 19352345

A global, evidence-based consensus on the definition of gastroesophageal reflux disease in the pediatric population.

Philip M Sherman1, Eric Hassall, Ulysses Fagundes-Neto, Benjamin D Gold, Seiichi Kato, Sibylle Koletzko, Susan Orenstein, Colin Rudolph, Nimish Vakil, Yvan Vandenplas.   

Abstract

OBJECTIVES: To develop an international consensus on the definition of gastroesophageal reflux disease (GERD) in the pediatric population.
METHODS: Using the Delphi process, a set of statements was developed and voted on by an international panel of eight pediatric gastroenterologists. Statements were based on systematic literature searches using Medline, EMBASE, and CINAHL. Voting was conducted using a six-point scale, with consensus defined, a priori, as agreed by 75% of the group. The strength of each statement was assessed using the GRADE system.
RESULTS: There were four rounds of voting. In the final vote, consensus was reached on 98% of the 59 statements. In this vote, 95% of the statements were accepted by seven of eight voters. Consensus items of particular note were: (i) GERD is present when reflux of gastric contents causes troublesome symptoms and/or complications, but this definition is complicated by unreliable reporting of symptoms in children under the age of approximately 8 years; (ii) histology has limited use in establishing or excluding a diagnosis of GERD; its primary role is to exclude other conditions; (iii) Barrett's esophagus should be defined as esophageal metaplasia that is intestinal metaplasia positive or negative; and (iv) extraesophageal conditions may be associated with GERD, but for most of these conditions causality remains to be established.
CONCLUSIONS: The consensus statements that comprise the Definition of GERD in the Pediatric Population were developed through a rigorous process. These statements are intended to be used for the development of future clinical practice guidelines and as a basis for clinical trials.

Entities:  

Mesh:

Year:  2009        PMID: 19352345     DOI: 10.1038/ajg.2009.129

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  86 in total

Review 1.  Gastroesophageal reflux disease--from reflux episodes to mucosal inflammation.

Authors:  Arne Kandulski; Peter Malfertheiner
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-11-22       Impact factor: 46.802

Review 2.  US in the diagnosis of gastroesophageal reflux in children.

Authors:  Alessandra Savino; Cristina Cecamore; Maria Ferrina Matronola; Alberto Verrotti; Angelika Mohn; Francesco Chiarelli; Piernicola Pelliccia
Journal:  Pediatr Radiol       Date:  2012-03-09

3.  Esophageal disease in pediatrics.

Authors:  Sudarshan R Jadcherla; Samuel Nurko
Journal:  Ann N Y Acad Sci       Date:  2011-09       Impact factor: 5.691

4.  Lansoprazole for children with poorly controlled asthma: a randomized controlled trial.

Authors:  Janet T Holbrook; Robert A Wise; Benjamin D Gold; Kathryn Blake; Ellen D Brown; Mario Castro; Allen J Dozor; John J Lima; John G Mastronarde; Marianna M Sockrider; W Gerald Teague
Journal:  JAMA       Date:  2012-01-25       Impact factor: 56.272

5.  Antigen presentation and MHC class II expression by human esophageal epithelial cells: role in eosinophilic esophagitis.

Authors:  Daniel J Mulder; Aman Pooni; Nanette Mak; David J Hurlbut; Sameh Basta; Christopher J Justinich
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

6.  Effect of proton pump inhibition on acid, weakly acid and weakly alkaline gastro-esophageal reflux in children.

Authors:  Helena Turk; Bruno Hauser; Jernej Brecelj; Yvan Vandenplas; Rok Orel
Journal:  World J Pediatr       Date:  2013-02-07       Impact factor: 2.764

Review 7.  Outcomes of pediatric laparoscopic fundoplication: a critical review of the literature.

Authors:  Kathryn Martin; Catherine Deshaies; Sherif Emil
Journal:  Can J Gastroenterol Hepatol       Date:  2013-11-28

Review 8.  Gastroesophageal reflux disease in neonates and infants : when and how to treat.

Authors:  Steven J Czinn; Samra Blanchard
Journal:  Paediatr Drugs       Date:  2013-02       Impact factor: 3.022

9.  Mucosal Impedance Measurements Differentiate Pediatric Patients With Active Versus Inactive Eosinophilic Esophagitis.

Authors:  Mary Allyson Lowry; Michael F Vaezi; Hernan Correa; Tina Higginbotham; James C Slaughter; Sari Acra
Journal:  J Pediatr Gastroenterol Nutr       Date:  2018-08       Impact factor: 2.839

10.  Proton pump inhibitor prescribing patterns in newborns and infants.

Authors:  Marta Illueca; Berhanu Alemayehu; Nze Shoetan; Huiying Yang
Journal:  J Pediatr Pharmacol Ther       Date:  2014 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.